Kestra Investment Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
4,745
+1,738
+58% +$744K 0.03% 143
2025
Q4
$1.29M Buy
3,007
+1,181
+65% +$514K 0.03% 177
2025
Q3
$817K Sell
1,826
-1,811
-50% -$820K 0.02% 218
2025
Q2
$1.99M Buy
3,637
+1,917
+111% +$1.09M 0.03% 187
2025
Q1
$1.06M Buy
1,720
+660
+62% +$375K 0.03% 162
2024
Q4
$561K Buy
1,060
+62
+6% +$35K 0.02% 212
2024
Q3
$600K Buy
+998
New +$566K 0.03% 184

Other funds holding CHE

Kestra Investment Management's CHE Position: Q1 2026 in Review

Kestra Investment Management increased its Chemed (CHE) stake by 58% in Q1 2026, buying an estimated $744K and bringing the position to 4,745 shares worth $1.79M. The position accounts for 0.03% of the portfolio, ranked #143.

Kestra Investment Management first reported a position in CHE in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.99M in Q2 2025. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Kestra Investment Management held 4,745 shares of Chemed worth $1.79M as of Q1 2026.
  • Kestra Investment Management bought 1,738 Chemed shares in Q1 2026, an estimated $744K.
  • Chemed made up 0.03% of Kestra Investment Management's portfolio in Q1 2026, its #143 holding.
  • Kestra Investment Management first reported a position in Chemed in Q3 2024 and has held it in 7 quarters since.
  • Kestra Investment Management's Chemed position peaked at $1.99M in Q2 2025.
  • 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Kestra Investment Management's 13F filing for Q1 2026, filed 11 May 2026.